CDK6 and neoplasm: Strong evidence exists supporting a tumor suppressor function for miR-33a via repression of proto-oncogene Pim-1 [48] and inhibition of expression of cyclin-dependent kinase 6 (CDK6) and cyclin D1 (CCDN1) [49], both of which results in reduced cellular proliferation and cell-cycle progression.